| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/25/2009 | CN101395172A Novel antimicrobial peptides and use thereof |
| 03/25/2009 | CN101394861A Extended release of neuregulin for improved cardiac function |
| 03/25/2009 | CN101392257A Genetic engineering application of nitrate transport protein genom OsNRT2.3 in Rice |
| 03/25/2009 | CN101392256A Gene synthesis of wild boar alpha-interferon, vector construction and method for producing outcome |
| 03/25/2009 | CN101392252A Lychas mucronatus Kv1.3 blocker gene, preparation method and application |
| 03/25/2009 | CN101392250A African horse sickness detection kit and detection method |
| 03/25/2009 | CN101392239A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 03/25/2009 | CN101392232A Application of dominant suppressing mutant F427D as anthrax bacillus toxin inhibitor and vaccine |
| 03/25/2009 | CN101392026A Polypeptide for preventing and treating fibrotic disease and liver cancer |
| 03/25/2009 | CN101392025A Plant anti-adversity associated protein and encoding gene and use thereof |
| 03/25/2009 | CN101392024A Rice tillering associated protein and encoding gene and use thereof |
| 03/25/2009 | CN101392023A Main allergic protein of humulus pollen |
| 03/25/2009 | CN101392022A Monoclonal antibody of main allergic protein of humulus pollen |
| 03/25/2009 | CN101392021A Protective antigen composition capable of excitating organism to generate immunity against plague and use thereof |
| 03/25/2009 | CN101392020A Musca domestic pupae natural antimicrobial peptide products and preparation method and use thereof |
| 03/25/2009 | CN101392019A Isolation and purification method of antifreeze protein from ammopiptanthus monogolicus leaf |
| 03/25/2009 | CN100471957C Adenovirus vectors for immunotherapy |
| 03/25/2009 | CN100471953C New CkNHX gene and shearing decorative gene CkNHXn, method for cultivating inverse-resistant plant |
| 03/25/2009 | CN100471945C Novel avian disease bacteria and bacterin derived therefrom |
| 03/25/2009 | CN100471870C Method for extracting and purifying glycoprotein from oyster shuck |
| 03/25/2009 | CN100471869C Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of coriolus versicolor |
| 03/25/2009 | CN100471868C Compositions and methods for WT1 specific immunotherapy |
| 03/25/2009 | CN100471521C Polypeptides having single covalently bound N-terminal water-soluble polymer |
| 03/24/2009 | US7507881 Plants and seeds of corn variety I291273 |
| 03/24/2009 | US7507875 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants |
| 03/24/2009 | US7507873 Transforming oviduct tissue of birds with nucleotide sequences coding mammalian polypeptides; bioreactors and heterologous gene expression; tissue engineering |
| 03/24/2009 | US7507872 Transgenic toll-like receptor 9 (TLR9) mice |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507805 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 03/24/2009 | US7507804 Peptides and nucleic acid sequences related to the Epstein Barr Virus |
| 03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
| 03/24/2009 | US7507801 therapies and screening methods for a variety of disorders including but not limited to: myeloid malignancies such as acute myelogenous leukemia, myelodysplastic syndrome, polycythemia vera and juvenile chronic myelogenous leukemia; autoimmune diso |
| 03/24/2009 | US7507799 High affinity ligand for p75 neurotrophin receptor |
| 03/24/2009 | US7507798 Antibody specific for mutant presenilin 1 |
| 03/24/2009 | US7507796 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507794 Isolated soluble corticotropin releasing factor receptor type 2 (sCRFR2) |
| 03/24/2009 | US7507793 Mammalian sweet taste receptors t1r3 |
| 03/24/2009 | US7507792 MDA-7 proteins and methods of use thereof |
| 03/24/2009 | US7507790 Plurality of peptide monomers each being attached at one end to a hub capable of interacting with a sub-unit of a self-assembling peptide to form an overlapping staggered structure or protein; purification of blood or biological fluids, cell assembly and tissue engineering |
| 03/24/2009 | US7507789 Detection of Anaplasma platys |
| 03/24/2009 | US7507788 Peptides and methods for cell death regulation |
| 03/24/2009 | US7507787 Polynucleotides; induce immunology response; antiinflammatory agents; detection polynucleotide patten |
| 03/24/2009 | US7507716 Method for treating pain with prolactin antagonists |
| 03/24/2009 | US7507714 For stimulating insulin release from pancreatic beta cells in glucose-dependent fashion; treatment of metabolic disorders such as those resulting from decreased endogenous insulin secretion, in particular type 2 diabetics, or for patients with impaired glucose tolerance |
| 03/24/2009 | US7507713 purified polypeptide and fusion protein for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; axonal regeneration, side effect reduction of scar tissue formation |
| 03/24/2009 | US7507712 NOV protein: an anti-angiogenic agent and its use, in particular for the treatment of cancer |
| 03/24/2009 | US7507710 Anti-amyloid immunogenic compositions, methods and uses |
| 03/24/2009 | US7507709 Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 03/24/2009 | US7507580 Ztnfr14, a tumor necrosis factor receptor |
| 03/24/2009 | US7507574 Recombinant Saccharomyces cerevisiae expressing chimeric glucose transporters |
| 03/24/2009 | US7507557 Nucleotide sequences coding proline utilization protein (PUT2) for use as tool in prevention and treatment of insulin metabolic disorders |
| 03/24/2009 | US7507556 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents |
| 03/24/2009 | US7507549 Method for following the progress of prostate cancer |
| 03/24/2009 | US7507544 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing |
| 03/24/2009 | US7507543 GABAB receptor polypeptides and screening methods |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507538 Human papilloma virus immunoreactive peptides |
| 03/24/2009 | US7507531 Using nucleic acid |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507417 Glycoproteins; antigens |
| 03/24/2009 | US7507415 West nile virus vaccine |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507408 Anti hepatitis C virus antibody and uses thereof |
| 03/24/2009 | US7507406 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/24/2009 | CA2466877C Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/24/2009 | CA2450690C Improved chelator conjugates |
| 03/24/2009 | CA2318479C G protein-related kinase mutants in essential hypertension |
| 03/24/2009 | CA2087271C Superior thrombomodulin analogs for pharmaceutical use |
| 03/24/2009 | CA2017186C Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 03/21/2009 | CA2602876A1 Tissue culture and cloning things |
| 03/19/2009 | WO2009036448A2 Natriuretic peptide receptor-c agonists |
| 03/19/2009 | WO2009036349A1 Hsp70-based treatment for autoimmune diseases |
| 03/19/2009 | WO2009036234A1 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 03/19/2009 | WO2009036228A2 Hepatitis b pre-s2 nucleic acid |
| 03/19/2009 | WO2009036167A1 Targeting of notch3 receptor function for cancer therapy |
| 03/19/2009 | WO2009036095A1 Engineered light-harvesting organisms |
| 03/19/2009 | WO2009036092A2 Mitochondria-targeted anti-tumour agents |
| 03/19/2009 | WO2009036067A2 Molecule production by photosynthetic organisms |
| 03/19/2009 | WO2009035929A2 Cardiovascular and brain cell therapy using intracellular ryanodine receptor modulation by the estrogen receptor beta |
| 03/19/2009 | WO2009035721A1 Storage area network extension over passive optical networks using parallel signal detection |
| 03/19/2009 | WO2009035417A1 Neuroprotective agents |
| 03/19/2009 | WO2009035395A1 A lung-surfactant product |
| 03/19/2009 | WO2009035330A1 Probiotic and compound derived thereof exhibiting immunomodulatory ability |
| 03/19/2009 | WO2009035323A1 High yield secretion of multimeric recombinant protein |
| 03/19/2009 | WO2009034779A1 Cancer diagnosis kit and cancer diagnosis method |
| 03/19/2009 | WO2009034436A2 'hematopoietic cells that express tmcc-1' |
| 03/19/2009 | WO2009034315A2 Vaccine |
| 03/19/2009 | WO2009034182A1 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 03/19/2009 | WO2009034158A2 Transgenic mice |
| 03/19/2009 | WO2009034134A2 Use of natriuretic peptides for treating angioedema syndromes |
| 03/19/2009 | WO2009034119A1 Improved derivatives of amylin |
| 03/19/2009 | WO2009034103A1 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 03/19/2009 | WO2009034041A2 Peptide sequences and compositions |